I agree that this site is using cookies. You can find further informations here.
X
Paul-Bellon, R.
565  results:
Search for persons X
?
1

Effets gonadiques des perturbateurs endocriniens:

Chevalier, N. ; Brucker-Davis, F. ; Hieronimus, S....
Annales d'Endocrinologie.  78 (2017)  4 - p. 204-205 , 2017
Link: https://doi.org/10.1016/..
 
?
2

L'effet prolifératif des xéno-estrogènes ne peut pas être s..:

Chevalier, N. ; Paul-Bellon, R. ; Fenichel, P.
Annales d'Endocrinologie.  77 (2016)  4 - p. 321 , 2016
Link: https://doi.org/10.1016/..
 
?
3

L'atrazine inhibe la prolifération in vitro de cellules sém..:

Chevalier, N. ; Paul-Bellon, R. ; Fenichel, P.
Annales d'Endocrinologie.  76 (2015)  4 - p. 328 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Comment peut-on expliquer les courbes dose–réponse non mono..:

Chevalier, N. ; Paul-Bellon, R. ; Bouskine, A..
Annales d'Endocrinologie.  74 (2013)  4 - p. 266 , 2013
Link: https://doi.org/10.1016/..
 
?
5

Estrogènes et cancer du testicule : l'extinction de deux va..:

Chevalier, N. ; Paul-Bellon, R. ; Camparo, P....
Annales d'Endocrinologie.  73 (2012)  4 - p. 271-272 , 2012
Link: https://doi.org/10.1016/..
 
?
6

The suppressor of cytokine signalling 2 (SOCS2) is a key re..:

Lebrun, P. ; Cognard, E. ; Gontard, P....
Diabetologia.  53 (2010)  9 - p. 1935-1946 , 2010
Link: https://doi.org/10.1007/..
 
?
7

Constitutive expression of suppressor of cytokine signallin..:

Lebrun, P. ; Cognard, E. ; Bellon-Paul, R....
Diabetologia.  52 (2009)  10 - p. 2201-2212 , 2009
Link: https://doi.org/10.1007/..
 
?
8

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
?
9

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
?
10

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
?
11

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
?
12

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
?
13

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
?
14

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
?
15

Caspase 1/11 Deficiency or Pharmacological Inhibition Mitig..:

Aira, L. E ; Goncalves, D ; Bossowski, J. P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jid.2018.11.031.  , 2019
Link: https://hal.science/hal-..
 
1-15